Elucidation of mechanism of disease resistance and persistence in chronic myeloid leukemia.
Chronic myeloid leukemia (CML) is a clonal disorder of the hematopoietic stem cell caused by the BCR-ABL receptor tyrosine kinase. Imatinib mesylate (IM) is an inhibitor of BCR-ABL and has been approved for the treatment of CML. IM is well tolerated and highly efficacious as it induces stable long-t...
Gespeichert in:
主要作者: | |
---|---|
其他作者: | |
格式: | Dissertation |
语言: | 英语 |
出版: |
Philipps-Universität Marburg
2011
|
主题: | |
在线阅读: | PDF-Volltext |
标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
No citations were found for this record.